Price
Frequently asked questions
What is PetIQ's market capitalization?
What is PetIQ's Price-to-Earnings (P/E) ratio?
What is the Earnings Per Share (EPS) for PetIQ?
What are the analyst ratings and target price for PetIQ's stock?
What is PetIQ's revenue over the trailing twelve months?
What is the EBITDA for PetIQ?
What is the free cash flow of PetIQ?
What is the 5-year beta of PetIQ's stock?
How many employees does PetIQ have, and what sector and industry does it belong to?
What is the free float of PetIQ's shares?
Financials
Market Cap
$926.34M5Y beta
1.74EPS (TTM)
$0.38Free Float
27.74MP/E ratio (TTM)
81.48Revenue (TTM)
$1.13BEBITDA (TTM)
$116.56MFree Cashflow (TTM)
$11.98MPricing
Analyst Ratings
The price target is $29.00 and the stock is covered by 5 analysts.
Buy
4
Hold
1
Sell
0
Information
PetIQ, Inc. is a pet medication and wellness company, which provides veterinary products and services. The Company operates through two segments: Products and Services. Products segment manufactures and distributes pet medication and health and wellness products to major United States retail and e-commerce channels through more than 60,000 points of distribution. It is focused its offerings on value-branded products, and third-party branded products for dogs and cats, including pet Rx medications, OTC medications, and wellness products. Services segment provides a comprehensive suite of services at approximately 2,600 community clinic locations and wellness centers hosted at retailers across 39 states. The segment’s services include diagnostic tests, vaccinations, prescription medications, microchipping, grooming and hygiene and wellness checks. The Rx pet medications products include flea and tick control, heartworm preventatives, arthritis, thyroid, and other specialty medications.
1,933
Biotechnology & Drugs
Health Care
Identifier
ISIN
Primary Ticker